This template doesn't support hiding the navigation bar.

  • EXECUTIVE SUMMARY

    I am a life sciences commercial leader with a record of business development and growing strategic accounts for genomics and multiomics technologies, with additional work in diagnostics and precision oncology. I have developed underperforming or low-adoption territories into major revenue contributors and introduced emerging technologies into new markets.

    My work has focused on strategic account development with pharmaceutical, biotechnology, clinical, and research organizations. I work with senior business and scientific leaders to develop high-value partnerships and negotiate complex agreements. My focus extends beyond individual sales to building customer relationships and commercial programs that drive sustained growth.

    I have led cross-functional initiatives involving commercial and technical teams, including global programs across North America and Europe. During a previous acquisition and integration period, I preserved project momentum while implementing change. Customer confidence and continuity during transitions have been central to my work.

    My scientific training allows me to engage with researchers and technical leaders while maintaining a commercial perspective. I understand why a technology matters scientifically and what needs to happen commercially for customers to adopt it at scale. This perspective has helped me identify emerging opportunities, develop new business, and move differentiated technologies into successful markets.

  • PROFESSIONAL EXPERIENCE

     

    Mission Bio

    Single Cell Genomics & Multiomics for clinical applications, hematology & oncology

    2022- 2024

    Section image

    Tecan Genomics / NuGEN Technologies

    2016 - 2022

    Section image

    Harvard University

    2011 – 2016

  • SKILLS

    Commercial

    • Business Development
    • Strategy & Negotiation
    • Account Management
    • Scientific Liaison, Genomics & Technology
    • Customer Advocacy
    • Project & Services Management
    • Leadership, Team & Talent Mentoring
    • Commercial CRM & ERP Systems
    • Corporate Development
    • Commercial SME

    Sales Achievements

    • Global Sales Award, Genomics Division
    • Led the US Sales Team in Revenue, YoY revenue growth, and exceeding quotas across portfolios
    • Strategic partnerships between Global Genomics and KOLs
    • New program enabling Automation Genomics adoption through private & public partnerships
    • New program enabling single-cell technology adoption for novel applications

    Next-Generation Sequencing

    • Biospecimen and library preparation
    • WGS, WES, DNA-Seq, ChIP-Seq, ATAC-Seq, CUT&RUN
    • Methyl-Seq, RRBS, cfDNA
    • TrueMethyl Sequencing
    • Targeted Sequencing
    • CRISPR & gene-editing validation
    • RNA-Seq (WT, mRNA)
    • FFPE & Stem Cell RNA-Seq
    • Single-cell & exosomal RNA-Seq

    Technologies

    • 10X Genomics Chromium & Mission Bio Tapestri
    • Tecan DreamPrep™ NGS for automated library prep & quantification
    • Illumina MiSeq, NextSeq, HiSeq, NovaSeq Series
    • Oxford Nanopore Technologies (ONT)
    • PacBio, Roche, Element
    • Agilent BioAnalyzer & TapeStation analysis
    • QPCR: ABI 7900, Bio-Rad CFX, digital droplet PCR
    • Standard BioTools Fluidigm
    • Affymetrix GeneChips

    Fields of Study

    • Disruptive Strategy
    • Business Analytics
    • Financial Accounting
    • Economics
    • Agile Essentials
    • Project Management

    • Single Cell Genomics & Protein Multiomics
    • Clinical Oncology Biomarker & Diagnostics
    • Cell & Gene Therapy
    • Molecular Biology & Biochemistry
    • Genetics & Rare Disease
    • Immunology & Infectious Disease

    Professional Contribution & Thought Leadership

    • Invited speaker | ImmunoMark Summit, US East | 2027
    • Invited Instructor and Course Co-Creator | Annual Course in Flow Cytometry | 2022 - 2024
    • Co-designed and taught the first Single Cell Genomics Course; qualifies for American Society for Clinical Pathology (ASCP) CE credits
    • Best Genomics Poster Award | American Physiological Society (APS)
    • AAAS Press Research Feature | EurekAlert!

    Mentorship

    • 1000 Girls, 1000 Futures | New York Academy of Sciences
    • Women & Mathematics Network
    • Howard Hughes Medical Institute Outreach Program
    • Wesleyan Alumni Network

  • EDUCATION

    Section image

    Harvard University

    Disruptive Strategy with Clayton Christensen

    Harvard Business School Online

    Section image

    Northeastern University

    Certificate in Bioinformatics

    Graduate College of Professional Studies

    Section image

    The Johns Hopkins University

    Masters of Science (ScM)

    Bloomberg School of Public Health

    Immunology & Molecular Microbiology

    Section image

    Wesleyan University

    Bachelor of Arts (BA)

    Molecular Biology & Biochemistry

    Activities: Kappa Alpha Theta

  • PUBLICATIONS

    Section image

    Cardiac Gene Expression: Methods and Protocols

    Expression Profiling Using Affymetrix GeneChips® Probe Arrays, Humana Press (2007).

    Martina Schinke-Braun, Jennifer A. Couget

    Large-scale microarray expression profiling studies have helped us understand basic biological processes and classify and predict cancer prognosis; they have also accelerated the identification of new drug targets. Affymetrix GeneChip® probe arrays are high-density oligonucleotide microarrays that are available for many prokaryotic and eukaryotic species. https://experiments.springernature.com/articles/10.1007/978-1-59745-030-0_2

    Oncogene

    Heparin-binding EGF-like growth factor is an early response gene to chemotherapy and contributes to chemotherapy resistance. Wang, F., Liu, R., Lee, S.W., Sloss, C.M., Couget, J., Cusack, J.C. Oncogene. 2007;26(14):2006-2016.doi:10.1038/sj.onc.1209999. PMID:17001310.

    FASEB Journal

    Transcriptional changes following restoration of SERCA2a levels in failing rat hearts. Del Monte, F., Dalal, R., Tabchy, A., Couget, J., Bloch, K.D., Peterson, R., et al. FASEB J. 2004;18(12):1474–1476. doi:10.1096/fj.04-1714fje. PMID:15247151.

    Proceedings of the National Academy of Sciences (PNAS)

    Transcriptome signature of irreversible senescence in human papillomavirus-positive cervical cancer cells. Wells, S.I., Aronow, B.J., Wise, T.M., Williams, S.S., Couget, J.A., Howley, P.M. Proc Natl Acad Sci U S A.2003;100(12):7093–7098. doi:10.1073/pnas.1232309100. PMID:12756294.

  • LET'S CHAT!

    Struggling to scale your NGS or advanced multiomics workflows? Stuck in sample-quality bottlenecks, assay-validation hurdles,

    or data constraints? Evaluating new market positioning, platform feasibility, or strategic territory growth?

    Optimizing commercial pipelines or sourcing reliable preclinical service providers?

  • CONTACT ME

    Message me above!

    Message me above

    Section image

    Zoom request

    Section image
    Section image

    Greater Boston

    New York City

Cookie Use
We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
Learn More